J A Royds

Summary

Affiliation: University of Otago
Country: New Zealand

Publications

  1. ncbi Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level
    Donia P Macartney-Coxson
    1Wakefield Gastroenterology Research Institute, Wellington, New Zealand
    BMC Cancer 8:187. 2008
  2. ncbi p53 promotes adenoviral replication and increases late viral gene expression
    J A Royds
    Department of Pathology, University of Otago, Dunedin, New Zealand
    Oncogene 25:1509-20. 2006
  3. ncbi p53 and disease: when the guardian angel fails
    J A Royds
    Department of Pathology, University of Otago, Dunedin, New Zealand
    Cell Death Differ 13:1017-26. 2006
  4. ncbi Exploitation of cell cycle and cell death controls by adenoviruses: the road to a productive infection
    I Alasdair Russell
    Cell Transformation Group, Department of Pathology, Dunedin School of Medicine, University of Otago, Box 913, Dunedin, New Zealand
    Prog Mol Subcell Biol 36:207-43. 2004
  5. ncbi p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors
    T L Slatter
    Department of Pathology, School of Medicine, University of Otago, Dunedin, New Zealand
    Cell Death Differ 17:540-50. 2010
  6. ncbi Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme
    V Hakin-Smith
    Institute for Cancer Studies, Medical School, Sheffield, UK
    Lancet 361:836-8. 2003
  7. ncbi Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis
    Z E Winters
    Imperial Cancer Research Fund Molecular Oncology Laboratory, University of Oxford Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK
    Eur J Cancer 37:2405-12. 2001
  8. ncbi Comparative genomic hybridization and pathological findings in atypical teratoid/rhabdoid tumour of the central nervous system
    S B Wharton
    Academic Unit of Pathology, University of Sheffield, Medical School, Sheffield, UK
    Neuropathol Appl Neurobiol 29:254-61. 2003
  9. ncbi Correlation of VEGF production with IL1 alpha and IL6 secretion by human pituitary adenoma cells
    S A Borg
    Hormone and Vascular Group, Academic Unit of Endocrinology, Division of Genomic Medicine, University of Sheffield Medical School, Sheffield S10 2RX, UK
    Eur J Endocrinol 152:293-300. 2005

Collaborators

  • A W Braithwaite
  • G Williams
  • R R Reddel
  • T L Slatter
  • Donia P Macartney-Coxson
  • S A Borg
  • I Alasdair Russell
  • V Hakin-Smith
  • S B Wharton
  • Z E Winters
  • R Mehta
  • C Holzhauer
  • C Rubio
  • P Ganesan
  • M Wilson
  • M A Baird
  • Serena Rooker
  • Teresa Ward
  • Richard S Stubbs
  • Rod A Lea
  • Kylie A Hood
  • David A Hall
  • Rosemary O'Connor
  • Anna Wiles
  • Hong Jun Shi
  • K E Kerry
  • R D Battersby
  • T H Jones
  • W R Timperley
  • W H Wallace
  • D W Hammond
  • M J McKay
  • D Levy
  • C Wardle
  • J W Ironside
  • M Teo
  • D A Jellinek
  • T Carroll
  • N C Hunt
  • M J Bradburn
  • A L Harris
  • H Turley
  • C J Norbury

Detail Information

Publications9

  1. ncbi Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level
    Donia P Macartney-Coxson
    1Wakefield Gastroenterology Research Institute, Wellington, New Zealand
    BMC Cancer 8:187. 2008
    ..We therefore examined 8p for genes involved in colorectal cancer progression...
  2. ncbi p53 promotes adenoviral replication and increases late viral gene expression
    J A Royds
    Department of Pathology, University of Otago, Dunedin, New Zealand
    Oncogene 25:1509-20. 2006
    ..These results have implications for the use of Ad mutants that are defective in p53 degradation, such as ONYX-015, as agents for the treatment of cancers...
  3. ncbi p53 and disease: when the guardian angel fails
    J A Royds
    Department of Pathology, University of Otago, Dunedin, New Zealand
    Cell Death Differ 13:1017-26. 2006
    ..Finally, we outline some evidence that abnormalities in p53 function contribute to the etiology of other non-neoplastic diseases...
  4. ncbi Exploitation of cell cycle and cell death controls by adenoviruses: the road to a productive infection
    I Alasdair Russell
    Cell Transformation Group, Department of Pathology, Dunedin School of Medicine, University of Otago, Box 913, Dunedin, New Zealand
    Prog Mol Subcell Biol 36:207-43. 2004
  5. ncbi p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors
    T L Slatter
    Department of Pathology, School of Medicine, University of Otago, Dunedin, New Zealand
    Cell Death Differ 17:540-50. 2010
    ..We predict that by keeping B-cell populations in check, p53-dependent apoptosis prevents irregular B cells from eventuating in lymphomas...
  6. ncbi Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme
    V Hakin-Smith
    Institute for Cancer Studies, Medical School, Sheffield, UK
    Lancet 361:836-8. 2003
    ..In patients with non-ALT tumours, telomerase activity did not affect survival (median 287 [199-375] vs 236 [230-242] days, p=0.275). We conclude that ALT is a prognostic indicator for patients with glioblastoma multiforme...
  7. ncbi Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis
    Z E Winters
    Imperial Cancer Research Fund Molecular Oncology Laboratory, University of Oxford Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK
    Eur J Cancer 37:2405-12. 2001
    ..Investigation of the subcellular distribution of cell cycle regulatory proteins, particularly p21(WAF1/CIP1), could provide valuable prognostic markers in breast cancer...
  8. ncbi Comparative genomic hybridization and pathological findings in atypical teratoid/rhabdoid tumour of the central nervous system
    S B Wharton
    Academic Unit of Pathology, University of Sheffield, Medical School, Sheffield, UK
    Neuropathol Appl Neurobiol 29:254-61. 2003
    ....
  9. ncbi Correlation of VEGF production with IL1 alpha and IL6 secretion by human pituitary adenoma cells
    S A Borg
    Hormone and Vascular Group, Academic Unit of Endocrinology, Division of Genomic Medicine, University of Sheffield Medical School, Sheffield S10 2RX, UK
    Eur J Endocrinol 152:293-300. 2005
    ..We have also looked at the relationship of tumour volume and invasive status to VEGF secretion...